BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7295527)

  • 1. Simple estimation of macrophage activity in tumour-bearing animals treated with Corynebacterium parvum.
    Wilson RG
    Br J Exp Pathol; 1981 Aug; 62(4):347-9. PubMed ID: 7295527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H; Himeno K; Miake S; Nomoto K
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Corynebacterium parvum on T cell dependent tumor regression.
    McBride WH; Peters LJ; Mason KA; Barrow G
    J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
    Milas L; Basic I; Kogelnik HD; Withers HR
    Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
    Mendiondo O; Suit H; Fixler H
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible mechanisms in the anti-tumour activity of C. parvum.
    Cullen RT
    Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice.
    Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():195-200. PubMed ID: 415919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of C. parvum therapy on intratumoral macrophage subpopulations.
    McBride WH; Moore K
    Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum.
    Maruyama Y; Coleman MS
    Cancer Res; 1978 Jun; 38(6):1617-20. PubMed ID: 647675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulating effect on in vitro cell growth of spleen cells from tumor bearing mice].
    Stanislawski L; Barski G
    Biomedicine; 1974 Mar; 20(2):146-53. PubMed ID: 4849772
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.